Back to search
FDAFDA · Food and drugs·Recall number D-0234-2026

OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 mg/1.7mL, Rx only, Made in Canada by Novocol Pharmaceutical of Canada, Inc., Distributed by Septodont, Inc., Louisville, Co, 80027, NDC 0362-0101-10

Published December 24, 2025 · Recall initiated: October 31, 2025

Summary

FDA records drug Class II recall D-0234-2026, published December 24, 2025 and initiated October 31, 2025. Recalling firm: Novocol Pharmaceutical of Canada, Inc.; Status: Ongoing; Reported quantity: 1,636 cartons; Lot: Lot: D05004E, expires: 04-30-2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container: cracked/broken cartridges

What to do

Voluntary: Firm initiated · Letter

Get an email if ORAVERSE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ORAVERSE
Manufacturer
Novocol Pharmaceutical of Canada, Inc.
Distributor
U.S.A. Nationwide
Lot
Lot: D05004E, expires: 04-30-2027
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was OraVerse, (Phentolamine Mesylate) Injection, 0.4 mg/1.7mL, packaged in a carton containing 10 cartridges, 0.4 mg/1.7mL, Rx only, Made in Canada by Novocol Pharmaceutical of Canada, Inc., Distributed by Septodont, Inc., Louisville, Co, 80027, NDC 0362-0101-10 recalled?

Yes. FDA published recall D-0234-2026 on December 24, 2025. Reported hazard: Defective container: cracked/broken cartridges

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ORAVERSE.